Literature DB >> 3495486

Potentiation of interleukin-2 activity by levamisole and imidazole.

J M Redondo, J A López-Guerrero, M Fresno.   

Abstract

Levamisole, a known antihelminthic drug, was able to affect IL-2 dependent proliferation of several T lymphocyte clones. Although levamisole did not replace IL-2 and had no effect at saturating IL-2 concentrations, it reduced by 2- to 4-fold the dose of IL-2 required to give 50% of the maximal DNA synthesis, the optimal concentration of levamisole being between 1 to 3 X 10(-4) M. This effect of levamisole was not due to an alteration of the kinetics of thymidine incorporation. Imidazole and other imidazole ring containing compounds, but not thiol-containing compounds, had similar effects to those of levamisole, suggesting a role of the imidazole ring in the potentiation of IL-2 activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495486     DOI: 10.1016/0165-2478(87)90088-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Levamisole monotherapy for oral lichen planus.

Authors:  Tai Hyok Won; Se Young Park; Bo Suk Kim; Phil Seung Seo; Seok Don Park
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

2.  Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.

Authors:  H Aksoy; S Baltaci; K Türkölmez; I Seçkiner; Y Bedük
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitro.

Authors:  Tina Friis; Anne-Marie Engel; Christine D Bendiksen; Line S Larsen; Gunnar Houen
Journal:  Cancers (Basel)       Date:  2013-06-24       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.